# Study on Ginkgo Biolba Extract Fifty and Mild Cognitive Impairment Associated With CSVD

> **NCT06495476** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 144 (estimated)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **DRUG:** Ginkgo biloba extract 50 dropping pills
- **DRUG:** Ginkgo biloba extract Ginkgo biloba extract 50 Drops simulant

## Key facts

- **NCT ID:** NCT06495476
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2024-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06495476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06495476, "Study on Ginkgo Biolba Extract Fifty and Mild Cognitive Impairment Associated With CSVD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06495476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*